\![GEN-BIO-TECH-MODEL-REPORT](images/GEN-BIO-TECH-MODEL-REPORT.png)

# Generative BioTech Model Report

## Why "Raptor"?
- **Raptor mini** is a lightweight, efficient LLM architecture designed for local deployment and rapid iteration. It trades off some raw capacity for speed, cost, and ease of fine-tuning, making it ideal for niche domains like generative biotechnology where data is sensitive and models must run in controlled environments.
- The name evokes agility and precision: in biotech applications you often need to generate or analyze sequences quickly without massive infrastructure.
- Using Raptor or similar small models also reduces the risk surface for IP leakage and makes it easier to audit behavior.

## Generative AI in Biotechnology
1. **Designing molecules & proteins**: LLMs can propose candidate DNA/RNA sequences, protein structures, or small molecules based on natural language prompts or constraints.
2. **Literature summarization**: With the explosion of papers, models help researchers stay up to date by extracting key findings and generating concise reports.
3. **Hypothesis generation**: By connecting disparate data points, generative models can suggest novel experiments or identify potential off-target effects.
4. **Automation of lab protocols**: Text-to-protocol translation reduces manual transcription errors and speeds up reproducibility.

## Risks and Ethical Considerations
- **Dual use**: Models that propose biological designs can be misused to create harmful agents. Access must be gated and outputs monitored.
- **Data privacy**: Training on proprietary or patient-related sequences requires strict anonymization and consent.
- **Regulatory compliance**: Outputs intended for real-world biological systems must meet FDA/EMA etc guidelines; models are not certifications.
- **Biological grounding**: Unlike natural language, biology follows physical laws; models must incorporate domain-specific constraints to avoid infeasible suggestions.

## Recommendations
- Use open, transparent model architectures (like Raptor) with documented training pipelines.
- Implement tiered access: simple Q&A for general users, locked-down design assistance for accredited labs.
- Log all queries and outputs; maintain an audit trail for accountability.
- Continuously evaluate models against adversarial prompts designed to elicit dual-use guidance.
- Collaborate with biosecurity experts to define a constitution/governance for generative biotech models.

## Conclusion
Generative models hold huge promise in biotechnology, but the choice of architecture (Raptor, GPT, etc.) and governance regime will determine whether they accelerate discovery or amplify risk. Light, auditable models combined with robust safety frameworks are a sensible starting point.